EHC - Encompass Health Corporation
NEXT EARNINGS:
Apr 29, 2026
EPS Est: $1.50
|
Rev Est: $1.6B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$151.50
DETAILS
HIGH:
$153.00
LOW:
$150.00
MEDIAN:
$151.50
CONSENSUS:
$151.50
UPSIDE:
44.51%
Market Cap:
10.55B
Volume:
807,981
Avg Volume:
1,218,063
52 Week Range:
92.53-127.99
Sector:
Healthcare
Industry:
Medical - Care Facilities
Beta:
0.58
Last Dividend:
$0.72
Exchange:
NYSE
Country:
US
Employees:
28,572
IPO Date:
1986-09-24
EPS (TTM):
5.63
P/E Ratio:
18.84
Revenue (TTM):
5.94B
Total Assets:
7.09B
Total Debt:
266.70M
Cash & Equiv:
72.20M
Rev Growth (5Y):
10.7%
EPS Growth (5Y):
14.4%
FCF Growth (5Y):
8.2%
ROCE:
16.8%
Debt/Equity:
0.08
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-05 | $1.46 | $1.29 | +13.2% | $1.5B | $1.6B | -2.5% |
| 2025-10-29 | $1.23 | $1.19 | +3.4% | $1.5B | $1.5B | -4.1% |
| 2025-08-04 | $1.40 | $1.23 | +13.8% | $1.5B | $1.4B | +2.1% |
| 2025-04-24 | $1.37 | $1.19 | +15.1% | $1.5B | $1.4B | +2.1% |
| 2025-02-06 | $1.17 | $1.05 | +11.4% | $1.4B | $1.4B | +1.7% |
| 2024-10-28 | $1.03 | $0.94 | +9.6% | $1.4B | $1.4B | -2.0% |
| 2024-08-05 | $1.11 | $1.01 | +9.9% | $1.3B | $1.3B | 0.0% |
| 2024-04-24 | $1.12 | $0.94 | +19.1% | $1.3B | $1.3B | +0.8% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.94B | 5.37B | 4.80B | 4.35B | 4.01B | 3.57B | 4.61B | 4.28B | 3.91B | 3.64B | 3.12B | 2.37B |
| Net Income | 566.20M | 455.70M | 352.00M | 271.00M | 412.20M | 284.20M | 358.70M | 292.30M | 271.10M | 247.60M | 183.10M | 222.00M |
| EPS | 5.63 | 4.53 | 3.54 | 2.72 | 4.15 | 2.87 | 3.65 | 2.99 | 2.73 | 2.77 | 2.02 | 2.46 |
| Total Assets | 7.09B | 6.53B | 6.10B | 5.64B | 6.86B | 6.45B | 6.08B | 5.23B | 4.89B | 4.68B | 4.61B | 3.41B |
| Total Debt | 266.70M | 2.71B | 2.93B | 2.99B | 3.48B | 3.54B | 3.35B | 2.51B | 2.58B | 3.02B | 3.17B | 2.13B |
| Cash & Equivalents | 72.20M | 85.40M | 104.20M | 21.80M | 49.40M | 224.00M | 94.80M | 69.20M | 54.40M | 40.50M | 61.60M | 66.70M |
| Operating Cash Flow | 1.18B | 1.00B | 850.80M | 705.80M | 715.80M | 704.70M | 635.30M | 762.40M | 657.20M | 605.50M | 484.80M | 444.90M |
| Free Cash Flow | 439.20M | 360.30M | 267.70M | 121.70M | 164.60M | 296.50M | 231.20M | 491.90M | 412.20M | 402.60M | 328.30M | 257.00M |
| FCF per Share | 4.37 | 3.61 | 2.69 | 1.23 | 1.66 | 3.01 | 2.36 | 5.02 | 4.40 | 4.52 | 3.67 | 2.96 |
| Book Value | 3.22B | 2.07B | 1.65B | 1.31B | 1.91B | 1.59B | 1.35B | 1.33B | 1.18B | 735.90M | 611.40M | 566.40M |
| Cash & ST Investments | 72.20M | 85.40M | 141.80M | 21.80M | 49.40M | 224.00M | 94.80M | 69.20M | 54.40M | 40.50M | 61.60M | 66.70M |
| ROC Equity | 0.18 | 0.22 | 0.21 | 0.21 | 0.22 | 0.18 | 0.27 | 0.22 | 0.23 | 0.34 | 0.30 | 0.39 |